New Deal
Boris Oklander
Founder and Chief Technology Officer at C2I GENOMICS
Manager
Deal Bio
Expertise (1)
Key Relationships
Announcement Date
Deal Value
C2i Genomics
The Mark Foundation For Cancer Research
£72m
13 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.